BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 18160274)

  • 1. Nanotoxicity: the growing need for in vivo study.
    Fischer HC; Chan WC
    Curr Opin Biotechnol; 2007 Dec; 18(6):565-71. PubMed ID: 18160274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of in vitro systems for nanotoxicology: methodological considerations.
    Stone V; Johnston H; Schins RP
    Crit Rev Toxicol; 2009; 39(7):613-26. PubMed ID: 19650720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo methods of nanotoxicology.
    Greish K; Thiagarajan G; Ghandehari H
    Methods Mol Biol; 2012; 926():235-53. PubMed ID: 22975969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zebrafish as a correlative and predictive model for assessing biomaterial nanotoxicity.
    Fako VE; Furgeson DY
    Adv Drug Deliv Rev; 2009 Jun; 61(6):478-86. PubMed ID: 19389433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensors as tools for quantitation, nanotoxicity and nanomonitoring assessment of engineered nanomaterials.
    Sadik OA; Zhou AL; Kikandi S; Du N; Wang Q; Varner K
    J Environ Monit; 2009 Oct; 11(10):1782-800. PubMed ID: 19809701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotoxicology: the molecular science point of view.
    Pumera M
    Chem Asian J; 2011 Feb; 6(2):340-8. PubMed ID: 20725923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles.
    Tsuji JS; Maynard AD; Howard PC; James JT; Lam CW; Warheit DB; Santamaria AB
    Toxicol Sci; 2006 Jan; 89(1):42-50. PubMed ID: 16177233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in assessing nanomaterial toxicology: a personal perspective.
    Geraci CL; Castranova V
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(6):569-77. PubMed ID: 20799267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approach to using mechanism-based structure activity relationship (SAR) analysis to assess human health hazard potential of nanomaterials.
    Lai DY
    Food Chem Toxicol; 2015 Nov; 85():120-6. PubMed ID: 26111809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute toxicological effects of copper nanoparticles in vivo.
    Chen Z; Meng H; Xing G; Chen C; Zhao Y; Jia G; Wang T; Yuan H; Ye C; Zhao F; Chai Z; Zhu C; Fang X; Ma B; Wan L
    Toxicol Lett; 2006 May; 163(2):109-20. PubMed ID: 16289865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotoxicology and in vitro studies: the need of the hour.
    Arora S; Rajwade JM; Paknikar KM
    Toxicol Appl Pharmacol; 2012 Jan; 258(2):151-65. PubMed ID: 22178382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging.
    Tomalia DA; Reyna LA; Svenson S
    Biochem Soc Trans; 2007 Feb; 35(Pt 1):61-7. PubMed ID: 17233602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics techniques for nanotoxicity investigations.
    Lv M; Huang W; Chen Z; Jiang H; Chen J; Tian Y; Zhang Z; Xu F
    Bioanalysis; 2015; 7(12):1527-44. PubMed ID: 26168257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research strategies for safety evaluation of nanomaterials, part V: role of dissolution in biological fate and effects of nanoscale particles.
    Borm P; Klaessig FC; Landry TD; Moudgil B; Pauluhn J; Thomas K; Trottier R; Wood S
    Toxicol Sci; 2006 Mar; 90(1):23-32. PubMed ID: 16396841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splendid one-dimensional nanostructures of zinc oxide: a new nanomaterial family for nanotechnology.
    Wang ZL
    ACS Nano; 2008 Oct; 2(10):1987-92. PubMed ID: 19206442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomaterials in the environment: from materials to high-throughput screening to organisms.
    Thomas CR; George S; Horst AM; Ji Z; Miller RJ; Peralta-Videa JR; Xia T; Pokhrel S; Mädler L; Gardea-Torresdey JL; Holden PA; Keller AA; Lenihan HS; Nel AE; Zink JI
    ACS Nano; 2011 Jan; 5(1):13-20. PubMed ID: 21261306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnology for the biologist.
    McNeil SE
    J Leukoc Biol; 2005 Sep; 78(3):585-94. PubMed ID: 15923216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological properties of engineered nanomaterials.
    Dobrovolskaia MA; McNeil SE
    Nat Nanotechnol; 2007 Aug; 2(8):469-78. PubMed ID: 18654343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of nanoparticle size, shape, and surface chemistry on biological systems.
    Albanese A; Tang PS; Chan WC
    Annu Rev Biomed Eng; 2012; 14():1-16. PubMed ID: 22524388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [General and specific aspects of the toxic properties of nanoparticles and other chemical substances in the context of classical toxicology].
    Zholdakova ZI; Sinitsyna OO; Kharchevnikova NV
    Gig Sanit; 2008; (6):12-6. PubMed ID: 19198250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.